CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Webinar attendees will gain a comprehensive overview of Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis, exploring suitability criteria, treatment options and the latest insight from London’s clinical leaders.
Hear from Dr Majid Kazmi, Consultant Haematologist and Dr Ben Turner, Consultant Neurologist at 6-7.30pm on Thursday, 21st November.
Key topics for discussion:
Also known as AHSCT or HSCT, this treatment reboots the immune system to halt the progression of MS.